José Aires Pereira Selected Research

Enema (Enemas)

1/2022	CAN SUCRALFATE ENEMA PREVENT COLITIS IN COLONIC SEGMENTS WITHOUT FECAL TRANSIT?
1/2021	Sucralfate enemas reduce the oxidative tissue damage and preserves the contents of E-cadherin and ?-catenin in colonic mucosa without fecal stream.
4/2019	Enemas with mesalazine increase the tissue contents of mucins in the colonic mucosa devoid of fecal stream.
1/2018	EVALUATION OF ENEMAS CONTAINING SUCRALFATE IN TISSUE CONTENT OF MUC-2 PROTEIN IN EXPERIMENTAL MODEL OF DIVERSION COLITIS.
4/2017	EVALUATION OF ENEMAS CONTAINING SUCRALFATE IN TISSUE CONTENT OF MUC-2 PROTEIN IN EXPERIMENTAL MODEL OF DIVERSION COLITIS.
1/2017	Anti-inflammatory effects of enemas containing an oily extract of curcumin in an experimental model of diversion colitis.
1/2017	Claudin-3 and occludin content in the glands of colonic mucosa devoid from fecal stream submitted to topical intervention with oil extract of Curcuma longa.
5/2015	Tissue content of sulfomucins and sialomucins in the colonic mucosa, without fecal stream, undergoing daily intervention with sucralfate.
9/2014	Evaluation of the application of enemas containing sucralfate in tissue content of neutral and acid mucins in experimental model of diversion colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José Aires Pereira Research Topics

Disease

18	Fistula 01/2022 - 09/2008
14	Colitis 01/2022 - 10/2009
14	Inflammation (Inflammations) 01/2022 - 10/2009
3	Neoplasms (Cancer) 09/2018 - 01/2011
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2011
2	Ulcerative Colitis 01/2020 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 09/2018 - 01/2011
1	Rupture 01/2022
1	Colic (Abdominal Cramps) 01/2021
1	Infections 01/2020
1	Extramammary Paget Disease (Paget Disease, Extramammary) 09/2018
1	Adenocarcinoma in Situ 09/2018
1	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 09/2018
1	Osteosarcoma (Osteogenic Sarcoma) 03/2018
1	Necrosis 03/2018
1	Pain (Aches) 03/2018
1	Wounds and Injuries (Trauma) 01/2016
1	Obesity 10/2015
1	Non-alcoholic Fatty Liver Disease 10/2015
1	Arthritis (Polyarthritis) 11/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2013
1	Adenocarcinoma 01/2011
1	Neoplasm Metastasis (Metastasis) 01/2011
1	Hypertrophy 10/2009
1	Crohn Disease (Crohn's Disease) 10/2009

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2010
5	Sucralfate (Carafate)FDA LinkGeneric 01/2022 - 09/2014
4	Claudin-3IBA 01/2022 - 04/2015
4	Infliximab (Remicade)FDA Link 01/2022 - 01/2019
4	Cadherins (E-Cadherin)IBA 01/2022 - 01/2011
3	OccludinIBA 01/2022 - 04/2015
3	CurcuminIBA 01/2017 - 11/2014
2	AntioxidantsIBA 01/2022 - 01/2017
2	MucinsIBA 04/2019 - 09/2014
2	Peroxidase (Myeloperoxidase)IBA 01/2017 - 10/2009
2	AcidsIBA 09/2014 - 10/2009
1	isoquercitrinIBA 01/2022
1	FlavonoidsIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	CollagenIBA 01/2021
1	CateninsIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Linseed Oil (Flaxseed Oil)IBA 01/2020
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2020
1	Dextrans (Dextran)FDA Link 01/2020
1	Olive OilIBA 01/2020
1	Mesalamine (Mesalazine)FDA LinkGeneric 04/2019
1	Imiquimod (Aldara)FDA LinkGeneric 09/2018
1	Tuberculin (PPD)IBA 09/2018
1	Photosensitizing Agents (Photosensitizers)IBA 03/2018
1	RadiopharmaceuticalsIBA 03/2018
1	Therapeutic UsesIBA 01/2017
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2016
1	Pentoxifylline (Trental)FDA LinkGeneric 10/2015
1	ZymosanIBA 11/2014
1	Prednisone (Sone)FDA LinkGeneric 11/2014
1	Alcian BlueIBA 09/2014
1	Periodic AcidIBA 09/2014
1	beta CateninIBA 01/2011
1	Indicators and Reagents (Reagents)IBA 01/2011
1	Hematoxylin (Haematoxylon)IBA 01/2011
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2011
1	Oxygen (Dioxygen)IBA 10/2010
1	Free RadicalsIBA 10/2010
1	DNA (Deoxyribonucleic Acid)IBA 06/2010
1	sulfomucinIBA 06/2010
1	SialomucinsIBA 06/2010
1	Pharmaceutical PreparationsIBA 10/2009
1	Ethanol (Ethyl Alcohol)IBA 10/2009
1	Methotrexate (Mexate)FDA LinkGeneric 10/2009
1	SolutionsIBA 10/2009
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2009
1	AdipokinesIBA 10/2009
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2009
1	CytokinesIBA 10/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009
1	Interleukin-10 (Interleukin 10)IBA 10/2009

Therapy/Procedure

18	Colostomy 01/2022 - 09/2008
9	Enema (Enemas) 01/2022 - 09/2014
3	Therapeutics 01/2022 - 03/2018
2	Laparotomy 04/2012 - 06/2010
1	Investigational Therapies (Experimental Therapy) 01/2022
1	Biological Therapy 10/2021
1	Jejunoileal Bypass 01/2021
1	Euthanasia (Mercy Killing) 04/2019
1	Anesthesia 03/2018
1	Photochemotherapy (Photodynamic Therapy) 03/2018
1	Oral Administration 11/2014